Human Health and Disease

HUMAN HEALTH AND DISEASE

Definition of Health

**Health** is not merely the absence of disease or physical fitness, but a state of **complete physical, mental and social well-being**. Health enables:

Increased work efficiency and productivity

Improved longevity

Reduced infant and maternal mortality

**Maintenance of health** requires:

Balanced diet

Personal hygiene

Regular exercise

Yoga (for physical and mental well-being)

Awareness about diseases and vaccination

Proper waste disposal

Vector control

Maintenance of hygiene in food and water resources

Disease: Definition and Classification

**Disease** occurs when the functioning of one or more organs or body systems is adversely affected, characterized by signs and symptoms.

**Diseases are classified into two main types:**

1. **Infectious diseases** — easily transmitted from one person to another; caused by pathogens (bacteria, viruses, fungi, protozoans, helminths). Examples: AIDS, malaria, typhoid, pneumonia.

2. **Non-infectious diseases** — not transmissible between individuals; include genetic disorders, cancer, lifestyle diseases.

---

COMMON DISEASES IN HUMANS

Pathogens and Disease Transmission

**Pathogens** are disease-causing organisms belonging to bacteria, viruses, fungi, protozoans, and helminths. Pathogens:

Enter the body through multiple routes

Multiply within the host

Interfere with normal vital activities

Adapt to survive in the host environment (e.g., surviving stomach pH, resisting digestive enzymes)

Bacterial Diseases

#### Typhoid Fever

**Causative agent:** *Salmonella typhi* (gram-negative bacterium)

**Transmission:** Contaminated food and water; pathogens migrate to other organs via blood

**Symptoms:** Sustained high fever (39–40°C), weakness, stomach pain, constipation, headache, loss of appetite

**Complications:** Intestinal perforation and death in severe cases

**Diagnosis:** **Widal test** (classic diagnostic method detecting antibodies against *Salmonella typhi*)

**Historical note:** Mary Mallon ("Typhoid Mary") — a cook who was a chronic carrier, spreading typhoid through food she prepared for several years

#### Pneumonia

**Causative agents:** *Streptococcus pneumoniae*, *Haemophilus influenzae*

**Target:** Alveoli (air-filled sacs) of lungs become filled with fluid

**Symptoms:** Fever, chills, cough, headache; lips and fingernails may turn gray to bluish

**Transmission:** Inhalation of droplets/aerosols from infected persons; sharing contaminated glasses and utensils

**Other bacterial diseases:** Dysentery, plague, diphtheria

Viral Diseases

#### Common Cold

**Causative agent:** Rhino viruses

**Target:** Nose and respiratory passages (not lungs)

**Symptoms:** Nasal congestion and discharge, sore throat, hoarseness, cough, headache, tiredness (last 3–7 days)

**Transmission:** Droplets from cough/sneezes, or through contaminated objects (pens, books, cups, doorknobs, keyboards)

Protozoan Diseases

#### Malaria

**Causative agent:** *Plasmodium* species (*P. vivax*, *P. malariae*, *P. falciparum*)

**Most severe form:** Malignant malaria caused by *P. falciparum* (can be fatal)

**Vector:** Female *Anopheles* mosquito

**Life cycle:**

1. **Sporozoites** (infectious form) enter human body through mosquito bite

2. Parasites initially multiply in **liver cells**

3. Subsequently attack **red blood cells (RBCs)** causing their rupture

4. Rupture releases toxic **haemozoin** → causes chills and high fever recurring every 3–4 days

5. When infected person is bitten by female *Anopheles*, parasites enter mosquito and undergo development

6. Parasites multiply to form sporozoites stored in **salivary glands** of mosquito

7. Upon next human bite, sporozoites are introduced, repeating the cycle

**Unique feature:** Requires **two hosts** — humans and mosquitoes to complete life cycle

#### Amoebiasis (Amoebic Dysentery)

**Causative agent:** *Entamoeba histolytica* (protozoan parasite in large intestine)

**Symptoms:** Constipation, abdominal pain and cramps, stools with excess mucous and blood clots

**Transmission:** Houseflies act as mechanical carriers; contaminated food and water from faeces of infected persons

**Prevention:** Clean drinking water and food hygiene

Helminthic (Parasitic Worm) Diseases

#### Ascariasis

**Causative agent:** *Ascaris* (common round worm); intestinal parasite

**Symptoms:** Internal bleeding, muscular pain, fever, anemia, intestinal blockage

**Transmission:** Eggs excreted in faeces contaminate soil, water, plants; infection via contaminated vegetables, fruits, water

**Prevention:** Personal and food hygiene; clean water

#### Filariasis (Elephantiasis)

**Causative agents:** *Wuchereria bancrofti*, *W. malayi* (filarial worms)

**Disease progression:** Slowly developing chronic inflammation of lymphatic vessels (usually lower limbs)

**Severe consequences:** Gross deformities of genital organs and lower limbs

**Transmission:** Female mosquito vectors

**Prevention:** Vector control (mosquito nets, insecticides, elimination of breeding sites)

Fungal Diseases

#### Ringworm

**Causative agents:** *Microsporum*, *Trichophyton*, *Epidermophyton* genera

**Affected areas:** Skin, nails, scalp; common infectious disease in humans

**Symptoms:** Dry, scaly lesions with intense itching

**Predisposing factors:** Heat and moisture; thrives in skin folds (groin, between toes)

**Transmission:** Soil contact; contaminated towels, clothes, combs of infected individuals

**Prevention:** Personal hygiene, keeping affected areas dry

Prevention and Control of Infectious Diseases

**Personal hygiene measures:**

Keep body clean

Consume clean drinking water

Eat clean vegetables and fruits

Proper disposal of wastes and excreta

**Public hygiene measures:**

Periodic cleaning and disinfection of water reservoirs, pools, tanks

Standard practices in public catering

Waste management systems

**For air-borne diseases (pneumonia, common cold):**

Avoid close contact with infected persons

Avoid sharing contaminated objects

**For vector-borne diseases (malaria, filariasis, dengue, chikungunya):**

Avoid stagnation of water in residential areas

Regular cleaning of household coolers

Use mosquito nets and wire mesh on doors/windows

Introduce fish species like *Gambusia* in ponds (feed on mosquito larvae)

Spray insecticides in ditches, drainage areas, swamps

**Biomedical approaches:**

**Vaccines and immunisation** — completely eradicated smallpox; controlled polio, diphtheria, pneumonia, tetanus

**Antibiotics and drugs** — effectively treat bacterial and other infections

**Biotechnology** — newer and safer vaccines in development

---

IMMUNITY

Definition

**Immunity** is the overall ability of the host to fight disease-causing organisms, conferred by the **immune system**. Despite daily exposure to infectious agents, only a few exposures result in disease due to this defense mechanism.

Types of Immunity

#### 1. Innate Immunity

**Innate immunity** is **non-specific defense**, present at birth. It provides barriers to prevent entry of foreign agents. Consists of four types:

**A. Physical Barriers:**

**Skin** — main barrier preventing microbial entry

**Mucus coating** — epithelium lining respiratory, gastrointestinal, and urogenital tracts trap microbes

**B. Physiological Barriers:**

**Stomach acid** — inhibits microbial growth

**Saliva** — antimicrobial properties

**Tears** — prevent microbial growth

**C. Cellular Barriers:**

**Polymorphonuclear leukocytes (PMNL/neutrophils)** — white blood cells that phagocytose microbes

**Monocytes** — engulf and destroy pathogens

**Natural killer (NK) cells** — type of lymphocytes; destroy virus-infected cells

**Macrophages** — tissue-resident cells; phagocytose foreign agents

**D. Cytokine Barriers:**

**Interferons** — proteins secreted by virus-infected cells

**Function:** Protect non-infected cells from further viral infection

**Role:** Prevent viral replication and spread

#### 2. Acquired Immunity

**Acquired immunity** is **pathogen-specific** and characterized by **memory**. Develops after exposure to pathogens.

**Primary response:**

Occurs upon first encounter with a pathogen

Low intensity

Slow to develop

**Secondary/Anamnestic response:**

Highly intensified response

Occurs upon subsequent exposure to same pathogen

Demonstrates immune memory

**Mediated by two types of lymphocytes:**

**B-lymphocytes:**

Produce **antibodies** (also called immunoglobulins) in response to pathogens

Antibodies are proteins that circulate in blood and bind to specific antigens

**Structure:** Each antibody has **H₂L₂** configuration

2 heavy chains (longer peptide chains)

2 light chains (smaller peptide chains)

**Types of antibodies:** IgA, IgM, IgE, IgG

**Response type:** **Humoral immune response** (antibody-mediated immunity)

**T-lymphocytes:**

Do not secrete antibodies

Help B cells produce antibodies

Mediate **cell-mediated immune response (CMI)** or **cell-mediated immunity**

**Function:** Responsible for graft rejection; differentiate 'self' from 'non-self'

**Clinical significance:** Organ transplant recipients require tissue matching, blood group matching, and lifelong immunosuppressants because T-cells recognize foreign tissue as 'non-self' and mount rejection response

Active vs. Passive Immunity

#### Active Immunity

**Definition:** Antibodies produced in the host body when exposed to antigens (living/dead microbes or proteins)

**Onset:** Slow; takes time for full effective response

**Induction methods:**

Deliberate injection of microbes during immunisation

Natural infection by pathogenic organisms

**Duration:** Long-lasting; memory cells provide sustained protection

**Examples:** Natural infection recovery, vaccination

#### Passive Immunity

**Definition:** Ready-made antibodies directly given to protect against foreign agents

**Onset:** Rapid; immediate protection

**Examples:**

**Colostrum** — yellowish fluid secreted by mother during initial lactation days; contains abundant **IgA antibodies** to protect newborn infant

**Placental transfer** — fetus receives antibodies from mother during pregnancy

**Antitoxins** — preformed antibodies injected in tetanus cases

**Snake bite serum** — contains preformed antibodies against snake venom

**Duration:** Short-lasting; disappears as administered antibodies are metabolized

Vaccination and Immunisation

**Principle:** Based on the **memory property of immune system**

**Mechanism:**

1. **Vaccine composition:** Preparation of antigenic proteins of pathogen OR inactivated/weakened pathogen

2. **Introduction:** Vaccine administered into the body (oral, intramuscular, intradermal)

3. **Primary response:** Antibodies produced against antigens in vaccine

4. **Memory formation:** **Memory B-cells and T-cells** generated

5. **Upon re-exposure:** Memory cells recognize pathogen quickly and elicit **secondary response** with massive antibody production

6. **Protection:** Neutralization of pathogenic agents during actual infection

**Types of Immunisation:**

**Active Immunisation:**

**Definition:** Vaccination introducing antigen to stimulate body's own immune response

**Examples:** Polio vaccine, diphtheria vaccine, pneumonia vaccine, tetanus vaccine, smallpox vaccine

**Outcome:** Long-term immunity through memory cells

**Passive Immunisation:**

**Definition:** Direct injection of preformed antibodies or antitoxins

**Examples:**

Tetanus — antitoxin injection for quick immune response

Snake bite — antivenom (preformed antibodies against venom)

Measles or hepatitis B post-exposure prophylaxis

**Outcome:** Immediate but temporary protection

**Public health impact:**

Smallpox — **completely eradicated** through vaccination programs

Polio, diphtheria, pneumonia, tetanus — **controlled to large extent** through vaccines

Future developments — Biotechnology enabling newer and safer vaccines

---

AIDS (Acquired Immunodeficiency Syndrome)

HIV Structure and Transmission

**HIV (Human Immunodeficiency Virus):**

**Type:** Retrovirus containing RNA genome

**Structure:** Envelope with glycoproteins; core containing RNA and enzymes (reverse transcriptase, integrase, protease)

**Target:** CD4+ T-lymphocytes (T-helper cells)

**Transmission routes:**

Unprotected sexual contact

Blood transfusion with contaminated blood

Sharing contaminated needles (intravenous drug users)

Mother-to-child transmission (during pregnancy, childbirth, breastfeeding)

HIV Replication Cycle

1. **Attachment:** HIV glycoproteins bind to CD4 receptors on T-lymphocyte surface

2. **Entry:** Virus enters the cell

3. **Reverse transcription:** **Reverse transcriptase** enzyme synthesizes DNA from viral RNA

4. **Integration:** Viral DNA integrates into host cell chromosome via **integrase** enzyme

5. **Transcription:** Integrated viral DNA (provirus) transcribed to produce viral RNA and proteins

6. **Assembly:** New viral particles assembled

7. **Budding:** New virions exit cell, acquiring envelope from host cell membrane

8. **Maturation:** **Protease** enzyme processes viral proteins for maturation of infectious particles

Stages of AIDS

**Stage 1 — Acute infection:**

Flu-like symptoms within 2–4 weeks of infection

High viral load, rapid CD4+ decline

Often asymptomatic or mistaken for flu

**Stage 2 — Latency period:**

Duration: 2–15 years (variable)

Few or no symptoms

Gradual CD4+ decline

Virus replicates slowly

**Stage 3 — AIDS:**

CD4+ count falls below 200 cells/μL

Opportunistic infections appear (*Pneumocystis jirovecii*, *Candida albicans*, tuberculosis)

Opportunistic malignancies (Kaposi's sarcoma, lymphomas)

Wasting syndrome

Prevention and Management

**Prevention strategies:**

Safe sexual practices and use of condoms

Testing and awareness programs

Screening of blood for transfusions

Needle exchange programs

Prevention of mother-to-child transmission (antiretroviral therapy during pregnancy and breastfeeding)

**Treatment (Antiretroviral Therapy — ART):**

**Combination therapy** using multiple drugs

**Classes of drugs:**

Reverse transcriptase inhibitors (NRTIs, NNRTIs)

Protease inhibitors

Integrase inhibitors

Entry inhibitors

**Outcome:** Suppresses viral replication, restores immune function, allows normal lifespan

---

CANCER

Definition and Classification

**Cancer** is a disease characterized by **uncontrolled cell division and growth**. Unlike normal cells, cancer cells lose contact inhibition and undergo unlimited mitotic divisions.

**Classification:**

**1. Based on origin:**

**Benign tumors** — non-cancerous; slow growth; localized; do not invade nearby tissues

**Malignant tumors** — cancerous; rapid growth; invasive; metastasize to distant sites

**2. Common types:**

**Carcinomas** — cancer of epithelial tissue (skin, lungs, breast, colon)

**Sarcomas** — cancer of connective tissue (bone, muscle)

**Lymphomas** — cancer of lymphoid tissue

**Leukemias** — cancer of blood-forming cells

Causes of Cancer

**1. Carcinogens — cancer-causing substances:**

**Chemical carcinogens:** Tobacco smoke, asbestos, benzene, pesticides

**Biological carcinogens:** Oncogenic viruses (HPV, EBV, hepatitis B virus)

**Physical carcinogens:** Ionizing radiation (X-rays, gamma rays), UV radiation

**2. Genetic factors:**

**Oncogenes** — mutated genes promoting cell growth (derived from proto-oncogenes)

**Tumor suppressor genes** — genes inhibiting cell division (e.g., p53, RB); loss-of-function mutations allow uncontrolled growth

**Hereditary cancer syndromes** — inherited mutations (BRCA1, BRCA2 in breast cancer)

Molecular Basis of Cancer

**Multi-step process:**

1. **Initiation:** Single cell acquires oncogenic mutation

2. **Promotion:** Repeated exposure to promoting factors causes additional mutations

3. **Progression:** Accumulation of 4–7 critical mutations

4. **Transformation:** Cell becomes fully malignant with loss of:

Contact inhibition

Cell cycle checkpoints

Apoptosis mechanisms

Differentiation capacity

**Key molecular changes:**

Activation of oncogenes (RAS, MYC, HER2)

Inactivation of tumor suppressor genes (p53, RB, PTEN)

Increased telomerase activity (prevents telomere shortening)

Angiogenesis — formation of new blood vessels to supply tumor

Cancer Prevention and Treatment

**Prevention:**

Avoid tobacco and alcohol

Reduce UV exposure (sunscreen, protective clothing)

Maintain healthy diet (high fiber, antioxidants)

Regular screening for early detection

Vaccination against oncogenic viruses (HPV vaccine)

**Treatment modalities:**

**Surgery:** Tumor removal

**Chemotherapy:** Cytotoxic drugs inhibit rapidly dividing cells

**Radiation therapy:** High-energy rays damage cancer cell DNA

**Immunotherapy:** Enhance body's immune response against cancer

**Targeted therapy:** Drugs targeting specific molecular abnormalities

**Combination therapy:** Multiple modalities for better outcomes

---

DRUGS AND ALCOHOL ABUSE

Definition and Classification

**Drug abuse** is the deliberate and excessive use of drugs without medical supervision, causing physical and mental harm. Substances commonly abused include:

**1. Opioids:**

**Examples:** Morphine, codeine, heroin, opium

**Source:** Natural alkaloids from opium poppy or synthetic derivatives

**Mechanism:** Bind to opioid receptors in brain and spinal cord

**Effects:**

Pain relief (legitimate medical use)

Euphoria and relaxation

Respiratory depression

Physical dependence and addiction

Withdrawal symptoms (pain, anxiety, insomnia, sweating)

**Consequences:** Overdose risk, respiratory failure, death; social deterioration

**2. Cannabinoids:**

**Source:** Cannabis sativa plant; active compound is THC (tetrahydrocannabinol)

**Forms:** Marijuana, hashish, cannabis oil

**Effects:**

Altered perception and cognition

Increased heart rate

Impaired memory and concentration

Anxiety and paranoia (especially in high doses)

Psychological dependence

**Long-term effects:** Chronic bronchitis (smoking), memory impairment, motivation loss, impaired academic/work performance

**3. Cocaine:**

**Source:** Coca plant alkaloid

**Forms:** Powder (snorted), crack (smoked)

**Mechanism:** Inhibits reuptake of dopamine, norepinephrine, serotonin; increases CNS stimulation

**Acute effects:** Euphoria, increased energy, confidence; followed by depression and crashes

**Cardiovascular effects:** Increased heart rate and blood pressure; risk of heart attack and stroke

**Dependence:** Highly addictive; psychological dependence severe

**Chronic effects:** Nasal septum perforation (snorting), lung damage (smoking), cardiac arrhythmias

Alcohol Abuse

**Ethanol (alcohol):**

**Source:** Fermentation of sugars

**CNS effect:** Depressant; affects neurotransmitter function

**Acute effects:** Impaired judgment, reduced inhibitions, slurred speech, poor motor coordination

**Chronic effects:**

**Liver damage:** Hepatitis, cirrhosis, fatty liver

**Gastrointestinal:** Gastritis, ulcers, esophageal cancer

**Neurological:** Peripheral neuropathy, Wernicke's encephalopathy, memory loss

**Cardiovascular:** Hypertension, cardiomyopathy, stroke

**Immunosuppression:** Increased susceptibility to infections

**Psychological:** Anxiety, depression, personality changes

**Social:** Domestic violence, accidents, legal issues

**Fetal effects:** Fetal alcohol spectrum disorder (growth retardation, intellectual disability, facial abnormalities)

**Dependence:** Physical and psychological; withdrawal symptoms include tremors, anxiety, seizures, delirium tremens

Health Consequences of Drug and Alcohol Abuse

**Toxicity:** Direct toxic effects on organs (liver, brain, heart, lungs)

**Dependence and addiction:** Compulsive use despite harmful effects

**Overdose:** Risk of fatal respiratory depression or cardiac arrest

**Infections:** HIV, hepatitis B and C (sharing contaminated needles)

**Malnutrition:** Poor dietary intake

**Mental health:** Depression, anxiety, psychosis

**Social consequences:** Family breakdown, unemployment, crime

**Accidents:** Impaired driving, injuries

Prevention and Rehabilitation

**Prevention strategies:**

Health education programs in schools and communities

Awareness campaigns about risks and consequences

Restriction of availability and distribution

Age restrictions on alcohol sales

Workplace drug testing

Community and family support programs

**Rehabilitation and treatment:**

**Detoxification:** Medical supervision during withdrawal

**Behavioral therapy:** Cognitive-behavioral therapy, motivational interviewing

**Pharmacological treatment:** Methadone, buprenorphine (opioid replacement); naltrexone (antagonist)

**Counseling:** Individual, group, family counseling

**Support groups:** Alcoholics Anonymous, Narcotics Anonymous

**Inpatient programs:** Residential treatment for severe addiction

**Relapse prevention:** Skills training and ongoing support

---

MICROBES IN HUMAN WELFARE

---

FOOD PROCESSING

Introduction

Microorganisms have been utilized for thousands of years in food processing, fermentation, and food preservation. These processes:

Enhance flavor and nutritional value

Preserve food through natural fermentation

Reduce pathogenic contamination

Produce beneficial probiotics

Fermentation by Lactobacillus (Curd/Yogurt Production)

**Organism:** *Lactobacillus* species (gram-positive, facultative anaerobic rods)

**Process of curd production:**

1. **Starter culture:** *Lactobacillus* bacteria added to warm milk

2. **Milk composition:** Contains lactose (milk sugar)

3. **Fermentation:** Lactobacilli ferment lactose through anaerobic respiration

4. **Lactic acid production:** Lactose → Pyruvate → Lactic acid

5. **pH reduction:** Accumulation of lactic acid lowers pH from 6.6 to ~4.6

6. **Casein precipitation:** Decreased pH causes milk protein casein to denature and precipitate

7. **Curd formation:** Casein aggregates form solid curd; whey is liquid byproduct

8. **Flavor development:** Lactobacilli produce diacetyl and acetoin compounds giving characteristic tangy flavor

**Nutritional benefits:**

Rich in protein and calcium

Contains beneficial probiotics (live lactobacilli)

Improved lactose digestibility

Production of B vitamins and bioactive compounds

Enhanced bioavailability of minerals

**Commercial applications:**

Yogurt production

Cheese production

Buttermilk and lassi (traditional Indian drink)

Fermentation by Saccharomyces (Bread and Wine Production)

**Organism:** *Saccharomyces cerevisiae* (unicellular ascomycete fungus)

#### Bread Production

**Process:**

1. **Dough preparation:** Yeast mixed into wheat flour dough with water and salt

2. **Glucose fermentation:** Saccharomyces ferments glucose anaerobically

Glucose → Pyruvate → Ethanol + CO₂

3. **Gas production:** CO₂ produced creates bubble nucleation sites

4. **Dough rising:** CO₂ trapped in dough matrix causes expansion; bread rises

5. **Baking:** Heat inactivates yeast; ethanol evaporates; CO₂ bubbles expand

6. **Bread structure:** Final bread has characteristic porous structure from gas pockets

**Advantages:**

Light, aerated crumb structure

Enhanced digestibility

Partial breakdown of gluten (beneficial for gluten sensitivity)

Extended shelf life through natural preservation

Development of characteristic bread flavor (yeast-derived compounds)

#### Wine Production

**Process:**

1. **Grape must:** Crushed grapes (glucose source) fermented with Saccharomyces

2. **Anaerobic fermentation:** Glucose → Ethanol + CO₂

3. **Fermentation period:** 1–3 weeks depending on yeast strain and temperature

4. **Alcohol production:** Yeast produces ethanol (typically 10–15% alcohol content)

5. **Secondary fermentation:** Malolactic bacteria convert malic acid to lactic acid (reduced acidity, smoother taste)

6. **Aging:** Oak barrel aging develops flavor complexity

7. **Bottling:** Final product with alcohol preserves wine

**Factors affecting wine quality:**

Yeast strain selection

Fermentation temperature

Sugar content of grapes

Aging duration and conditions

Fermentation by Propionibacterium (Swiss Cheese Production)

**Organism:** *Propionibacterium acnes* (or *Propionibacterium freudenreichii*, anaerobic gram-positive rod)

**Process:**

1. **Curd preparation:** Milk curdled using rennet and lactic acid bacteria

2. **Initial aging:** Lactic acid bacteria ferment lactose to lactic acid

3. **Propionibacterium inoculation:** Propionibacteria added to cheese curds

4. **Propionic acid fermentation:** Propionibacteria ferment lactic acid

Lactic acid → Propionic acid + Acetic acid + CO₂

5. **Characteristic hole formation:** CO₂ produced creates spherical "eyes" (holes) in cheese

6. **Flavor development:** Propionic and acetic acids produce characteristic nutty, mild flavor

7. **Aging period:** 3–12 months depending on desired size of holes and flavor intensity

**Distinctive features:**

Pale yellow color

Large spherical holes (eyes)

Mild, slightly sweet nutty flavor

Semi-firm to firm texture

**Nutritional value:**

High protein and calcium content

Beneficial gut bacteria (probiotics)

Enhanced vitamin absorption through fermentation

---

INDUSTRIAL PRODUCTION OF MICROBES AND METABOLITES

Antibiotic Production: Penicillin from Penicillium

**Discovery and significance:**

**Discoverer:** Alexander Fleming (1928) — accidental discovery of penicillin from contaminating *Penicillium notatum* mold

**Significance:** First widely used antibiotic; revolutionized bacterial infection treatment

**Impact:** Reduced mortality from bacterial infections; enabled complex surgical procedures

**Penicillin production process:**

**Industrial fermentation:**

1. **Culture selection:** High-yielding strains of *Penicillium chrysogenum* or *P. notatum* selected through mutagenesis

2. **Inoculum preparation:** Fungal spores grown in seed culture

3. **Fermentation medium:**

Lactose or glucose (carbon source)

Corn steep liquor (nitrogen source, vitamins)

Inorganic salts

pH maintained at 6–7

4. **Fermentation conditions:**

Temperature: 24–26°C (optimal for penicillin production)

Aeration: Mandatory for good growth and antibiotic synthesis

Fermentation duration: 7–14 days

5. **Upstream processing:** Mycelium filtered or separated from medium

6. **Extraction:** Penicillin extracted from filtrate using solvent extraction

7. **Purification:** Chromatographic techniques isolate pure penicillin

8. **Crystallization:** Penicillin converted to stable form (penicillin G or V)

9. **Formulation:** Stabilized product formulated for pharmaceutical use

**Penicillin structure and mechanism:**

**β-lactam antibiotic** containing 4-membered lactam ring fused to 5-membered thiazolidine ring

**Mechanism:** Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins; prevents transpeptidation cross-linking

**Selectivity:** Bacterial cell wall synthesis targeted; human cells lack cell walls (safe)

**Spectrum:** Effective against gram-positive and some gram-negative bacteria

**Resistance:** Bacterial β-lactamase enzyme hydrolyzes β-lactam ring; resistance growing

**Clinical importance:**

Treatment of streptococcal infections, syphilis, gonorrhea

Surgical prophylaxis

Dental infections

Citric Acid Production from Aspergillus

**Organism:** *Aspergillus niger* (fungus)

**Industrial fermentation:**

1. **Medium composition:**

Molasses or glucose (high sugar concentration, 120–150 g/L)

Low nitrogen (limiting nutrient, forces citric acid accumulation)

Inorganic salts and trace elements

pH 5.5–6.0 (acidic, preventing competing pathways)

2. **Fermentation conditions:**

Temperature: 25–30°C

High aeration rate (obligate requirement)

Fermentation duration: 7–12 days

Anaerobic conditions inhibited (favors citric acid accumulation)

3. **Fermentation process:**

*Aspergillus* grows as submerged mycelium

Glucose → Pyruvate → Acetyl-CoA → Citrate (citric acid cycle)

Citric acid accumulates as low nitrogen forces overflow metabolism

Mycelium separated by filtration

4. **Recovery:**

Citric acid extracted from filtrate

Crystallization as citric acid monohydrate

Purification and drying

**Applications:**

Food preservation and flavor (widely used in beverages, candies)

Pharmaceutical formulations

Detergent and cleaning products

Metal treatment and electroplating

Cosmetics and personal care products

**Advantages of fermentation over chemical synthesis:**

Lower production cost

Fewer toxic byproducts

Sustainability through renewable substrates

Higher product yield and purity

Ethanol Production

**Organism:** *Saccharomyces cerevisiae* (primary), *Zymomonas mobilis* (specialized)

**Industrial fermentation:**

1. **Raw materials:**

Molasses (sugarcane byproduct) — most economical

Corn syrup or glucose

Starch (from corn, potatoes) — requires enzymatic hydrolysis to glucose first

2. **Fermentation process:**

Yeast inoculum added to sterile medium

Temperature: 25–30°C

Anaerobic conditions preferred (maximizes ethanol, minimizes biomass)

pH maintained at 4–5

Duration: 2–10 days depending on scale

3. **Glucose fermentation:**

Glucose → 2 Pyruvate (glycolysis)

2 Pyruvate → 2 Ethanol + 2 CO₂ (Pasteur pathway)

Theoretical yield: 0.51 g ethanol per g glucose

4. **Ethanol recovery:**

Fermented broth contains 5–15% ethanol

Distillation separates ethanol (boiling point 78°C) from water

Rectification produces 95% ethanol

Dehydration using molecular sieves produces absolute ethanol (>99%)

**Applications:**

**Beverage industry:** Beer (~4–6% alcohol), wine (10–15%), spirits/whiskey (40–50%)

**Fuel:**